https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-09-04 / Cancer Immunol Immunother 2023 Nov;72(11):3727-3738
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-09-04 / Cancer Immunol Immunother 2023 Nov;72(11):3727-37382023-09-04 00:00:002023-09-04 00:00:00Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-09-01 / Clin Exp Med 2023 Dec;23(8):4431-4447
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-09-01 / Clin Exp Med 2023 Dec;23(8):4431-44472023-09-01 00:00:002023-09-01 00:00:00Breast cancer immunotherapy: a comprehensive review
